BCR-ABL1 [V468F]/BaF3
CBP73308
| I. Introduction | |
| Cell Line Name: | BCR-ABL1 [V468F]/BaF3 | 
| Host Cell: | Ba/F3 | 
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) | 
| Application: | Anti-proliferation assay and PD assay | 
| Freeze Medium: | 90% FBS+10% DMSO | 
| Complete Culture Medium: | RPMI-1640+10%FBS | 
| Mycoplasma Status: | Negative | 
| II. Background | |
| Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
| III. Representative Data | |
| 1.WB of BCR-ABL1 [V468F]/BaF3 
 | |
| 2.Sanger of BCR-ABL1 [V468F]/BaF3   Figure 2. BCR-ABL1 [V468F]/BaF3 V468F 
 Figure 3. BCR-ABL1 [V468F]/BaF3 Fusion | |
| 3. Anti-proliferation assay 
 Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 V468F Cells (C7). | |
 
            




 
             
             
         
             
             
             
             
             
             
            